Share This Article:

Psychiatric Comorbidity in Patients with Psoriasis, Vitiligo, Acne, Eczema and Group of Patients with Miscellaneous Dermatological Diagnoses

Abstract Full-Text HTML Download Download as PDF (Size:921KB) PP. 168-175
DOI: 10.4236/ojpsych.2014.43022    3,191 Downloads   4,658 Views   Citations

ABSTRACT

Background: Dermatological conditions can be associated with high psychiatric comorbidity. Several studies reported high rates of depression and anxiety particularly for specific dermatological disorders such as psoriasis and acne. Aim: The aim of this study was to compare the rates of psychiatric symptoms in patients with psoriasis, acne, vitiligo, and eczema versus patients who had other dermatological conditions; and to compare each dermatological group versus healthy control subjects. Methods: This prospective cross-sectional study was conducted in dermatology outpatient clinics in Khartoum. Hospital Anxiety and Depression Scale (HADS) was used to assess symptoms of anxiety (HADS-A) and depression (HADS-D). ICD-10 criteria were used for clinical psychiatric diagnosis. Tabulated results were analyzed using Chi-square test. Significance was set at P < 0.05. Results: HADS-D scores above the cut off points were significantly higher in patients with psoriasis (P = 0.0062), vitiligo (P = 0.0054), acne (P = 0.0103) and eczema (P = 0.0359) compared with healthy subjects. Similarly, HADS-A scores above the cut off points were significantly higher in patients with psoriasis (P < 0. 0.0001), vitiligo (P = 0.0001), acne (P = 0.0143) and eczema (P = 0.0281) compared with healthy subjects. No significant difference between the control group and patients with other dermatologic conditions regarding both HADS-D and HADS-A scores. Using ICD-10 criteria for clinical psychiatric diagnoses indicated that 52.3% of dermatology patients had an associated ICD-10 diagnosis; most commonly anxiety disorders (28.6%), and depression (21.9%). ICD-10 diagnoses of anxiety disorders included: OCD (13.3%) generalized anxiety disorder (5.7%), panic disorder (4.8%), phobic anxiety disorder (3.8%) and post-traumatic stress disorder (0.95%). Conclusion: Dermatological conditions are associated with high rates of psychiatric comorbidity. Screening for anxiety and depressive symptoms may be helpful for early diagnosis and management of associated psychiatric symptoms.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Mufaddel, A. and Abdelgani, A. (2014) Psychiatric Comorbidity in Patients with Psoriasis, Vitiligo, Acne, Eczema and Group of Patients with Miscellaneous Dermatological Diagnoses. Open Journal of Psychiatry, 4, 168-175. doi: 10.4236/ojpsych.2014.43022.

References

[1] Jafferany, M. (2007) Psychodermatology: A Guide to Understanding Common Psychocutaneous Disorders. Prim. Care Companion. Journal of Clinical Psychiatry, 9, 203-213.
[2] Osman, O.T., Mufaddel, A., Almugaddam, F. and Augusterfer, E. (2011) The Psychiatric Aspects of Skin Disorders. Expert Review of Dermatology, 6, 195-209. http://dx.doi.org/10.1586/edm.11.10
[3] Gupta, M.A. and Gupta, A.K. (2003) Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders: Epidemiology and Management. American Journal of Clinical Dermatology, 4, 833-842. http://dx.doi.org/10.2165/00128071-200304120-00003
[4] Hall, J.M., Cruser, D., Podawiltz, A., Mummert, D.I., Jones, H. and Mummert, M.E. (2012) Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis. Dermatology Research and Practice, 2012, Article ID: 403908. http://dx.doi.org/10.1155/2012/403908
[5] Kemeny, M.E. and Scheslowski, M. (2007) Understanding the Interaction between Psychological Stress and Immune-Related Diseases: A Stepwise Progression. Brain, Behavior, and Immunity, 21, 1009-1018. http://dx.doi.org/10.1016/j.bbi.2007.07.010
[6] Buske-Kirschbaum, A. and Hellhammer, D.H. (2003) Endocrine and Immune Responses to Stress in Chronic Inflammatory Skin Disorders. Annals of the New York Academy of Sciences, 992, 231-240. http://dx.doi.org/10.1111/j.1749-6632.2003.tb03153.x
[7] Gupta, M.A. and Gupta, A.K. (1998) Depression and Suicidal Ideation in Dermatology Patients with Acne, Alopecia areata, Atopic Dermatitis and Psoriasis. British Journal of Dermatology, 139, 846-850.
http://dx.doi.org/10.1046/j.1365-2133.1998.02511.x
[8] Barankin, B. and DeKoven, J. (2002) Psychological Effect of Common Skin Diseases. Canadian Family Physician, 48, 712-716.
[9] Uhlenhake, E., Yentzer, B.A. and Feldman, S.R. (2010) Acne Vulgaris and Depression: A Retrospective Examination. Journal of Cosmetic Dermatology, 9, 59-63. http://dx.doi.org/10.1111/j.1473-2165.2010.00478.x
[10] Wysowski, D.K., Pitts, M. and Beitz, J. (2001) An Analysis of Reports of Depression and Suicide in Patients Treated with Isotretinoin. Journal of the American Academy of Dermatology, 45, 515-519.
http://dx.doi.org/10.1067/mjd.2001.117730
[11] Zigmond, A.S. and Snaith, R.P. (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370. http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x
[12] Windemuth, D., Stücker, M., Hoffmann, K. and Altmeyer, P. (1999) Prevalence of Psychological Symptoms in Dermatologic Patients of an Acute Clinic. Der Hautarzt, 50, 338-343.
http://dx.doi.org/10.1007/s001050050917
[13] Aktan, S., Ozmen, E. and Sanli, B. (1998) Psychiatric Disorders in Patients Attending a Dermatology Outpatient Clinic. Dermatology, 197, 230-234. http://dx.doi.org/10.1159/000018002
[14] Picardi, A., Abeni, D., Melchi, C.F., Puddu, P. and Pasquini, P. (2000) Psychiatric Morbidity in Dermatological Outpatients: An Issue to Be Recognized. British Journal of Dermatology, 143, 983-991. http://dx.doi.org/10.1046/j.1365-2133.2000.03831.x
[15] Picardi, A., Abeni, D., Renzi, C., Braga, M., Melchi, C.F. and Pasquini, P. (2003) Treatment Outcome and Incidence of Psychiatric Disorders in Dermatological Out-Patients. Journal of the European Academy of Dermatology and Venereology, 17, 155-159. http://dx.doi.org/10.1046/j.1468-3083.2003.00619.x
[16] Arbabi, M., Zhand, N., Samadi, Z., Ghaninejad, H. and Golestan, B. (2009) Psychiatric Comorbidity and Quality of Life in Patients with Dermatologic Diseases. Iranian Journal of Psychiatry, 4, 102-106.
[17] Hughes, J.E., Barraclough, B.M., Hamblin, L.G. and White, J.E. (1983) Psychiatric Symptoms in Dermatology Patients. The British Journal of Psychiatry, 143, 51-54.
http://dx.doi.org/10.1192/bjp.143.1.51
[18] Picardi, A., Pasquini, P., Abeni, D., Fassone, G., Mazzotti, E. and Fava, G.A. (2005) Psychosomatic Assessment of Skin Diseases in Clinical Practice. Psychotherapy and Psychosomatics, 74, 315-322. http://dx.doi.org/10.1159/000086323
[19] Aslam, R., Qadir, A. and Asad, F. (2007) Psychiatric Morbidity in Dermatological Outpatients: An Issue to Be Recognized. Journal of Pakistan Association of Dermatologists, 17, 235-223.
[20] Filakovic, P., Petek, A., Koic, O., Radanovic-Grguric, L. and Degmecic, D. (2009) Comorbidity of Depressive and Dermatologic Disorders—Therapeutic Aspects. Psychiatria Danubina, 21, 401-410.
[21] Gieler, U., Consoli, S.G., Tomas-Aragones, L., Linder, D.M., Jemec, G.B. and Poot, F. (2013) Self-Inflicted Lesions in Dermatology: Terminology and Classification—A Position Paper from the European Society for Dermatology and Psychiatry (ESDaP). Acta Dermato-Venereologica, 93, 4-12.
[22] Rotge, J.Y., Guehl, D., Dilharreguy, B., Cuny, E., Tignol, J., Bioulac, B., Allard, M., Burbaud, P. and Aouizerate, B. (2008) Provocation of Obsessive-Compulsive Symptoms: A Quantitative Voxel-Based Meta-Analysis of Functional Neuroimaging Studies. Journal of Psychiatry and Neuroscience, 33, 405-412.
[23] Leknes, S.G., Bantick, S., Willis, C.M., Wilkinson, J.D., Wise, R.G. and Tracey, I. (2007) Itch and Motivation to Scratch, an Investigation of the Central and Peripheral Correlates of Allergen and Histamine-Induced Itch in Humans. Journal of Neurophysiology, 97, 415-422.
http://dx.doi.org/10.1152/jn.00070.2006
[24] Turka, L.A., Goodman, R.E., Rutkowski, J.L., Sima, A.A., Merry, A., Mitra, R.S., Wrone-Smith, T., Toews, G., Strieter, R.M. and Nickoloff, B.J. (1995) Interleukin 12: A Potential Link between Nerve Cells and the Immune Response in Inflammatory Disorders. Molecular Medicine, 1, 690-699.
[25] Pacan, P., Szepietowski, J.C. and Kiejna, A. (2003) Stressful Life Events and Depression in Patients Suffering from Psoriasis Vulgaris. Dermatology and Psychosomatics, 4, 142-145.
http://dx.doi.org/10.1159/000073990
[26] Yazici, K., Baz, K. and Yazici, A.E. (2004) Disease-Specific Quality of Life Is Associated with Anxiety and Depression in Patients with Acne. Journal of the European Academy of Dermatology and Venereology, 18, 435-439. http://dx.doi.org/10.1111/j.1468-3083.2004.00946.x
[27] Gupta, M.A. and Gupta, A.K. (1996) Psychodermatology: An Update. Journal of the American Academy of Dermatology, 34, 1030-1046. http://dx.doi.org/10.1016/S0190-9622(96)90284-4
[28] Ritvo, E., Del Rosso, J.Q., Stillman, M.A. and La Riche, C. (2011) Psychosocial Judgments and Perceptions of Adolescents with Acne Vulgaris: A Blinded, Controlled Comparison of Adult and Peer Evaluations. BioPsychoSocial Medicine, 5, 11. http://dx.doi.org/10.1186/1751-0759-5-11

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.